The CCL22-CCR4 axis is known to chemo-attract regulatory T cells (Tregs) into tumor tissues; Tregs recognize self-antigens, including tumor antigens present in tumor tissues, and efficiently suppress the activation of tumor antigen-specific effector T cells [27]. This evidence concerns the gene CCR4 and neoplasm.